Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 225 of 226 entries
View as:

Targeting PD-L1 and TIGIT in Tumors With Tertiary Lymphoid Structures

Phase: N/A Priority: Normal
NCT ID: NCT06713798 Org: User:
Start: 07/31/25 End: 01/31/30 Due: 01/31/31

Confocal Micro-endoscopy in Head and Neck Cancer/Micro Endoscopie Confocale (MEC)Oto-Rhino-Laryngologie (ORL)

Phase: N/A Priority: Normal
NCT ID: NCT01626638 Org: User:
Start: 02/01/13 End: 05/24/17 Due: 05/24/18

Differentiated Thyroid Cancer: is There a Need for Radioiodine Ablation in Low Risk Patients?

Phase: N/A Priority: Normal
NCT ID: NCT01837745 Org: User:
Start: 05/13/13 End: 01/01/30 Due: 01/01/31

Basket Trial for Combination Therapy With Durvalumab (Anti-PDL1) (MEDI4736) and Tremelimumab (Anti-CTLA4) in Patients With Metastatic Solid Tumors

Phase: N/A Priority: Normal
NCT ID: NCT03982173 Org: User:
Start: 09/30/20 End: 12/05/24 Due: 12/05/25

Patritumab Deruxtecan (U3-1402) in Unresectable Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT04965766 Org: User:
Start: 05/11/21 End: 04/11/28 Due: 04/11/29

High Risk Primitive Neuroectodermal (PNET) Brain Tumors in Childhood

Phase: N/A Priority: Normal
NCT ID: NCT00180791 Org: User:
Start: 07/31/02 End: - Due: -

Treatment of High-Risk Cerebral Primitive Neuroectodermal Tumors in Children Aged Over 5 Years

Phase: N/A Priority: Normal
NCT ID: NCT00936156 Org: User:
Start: 01/31/09 End: 01/31/12 Due: 01/31/13

European Proof-of-Concept Therapeutic Stratification Trial of Molecular Anomalies in Relapsed or Refractory Tumors

Phase: N/A Priority: Normal
NCT ID: NCT02813135 Org: User:
Start: 08/03/16 End: 02/28/31 Due: 02/28/32

Trial of Superiority of Stereotactic Body Radiation Therapy in Patients With Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT02089100 Org: User:
Start: 02/28/14 End: 02/28/26 Due: 02/28/27

Therapeutic Strategy Guided by PET-TDM for Patients With Seminoma

Phase: N/A Priority: Normal
NCT ID: NCT01887340 Org: User:
Start: 06/30/13 End: 06/30/26 Due: 06/30/27

Prospective Analysis of Circulating Nucleosomes in Patients Receiving a First Line Treatment for a Non-Hodgkin Lymphoma

Phase: N/A Priority: Normal
NCT ID: NCT06813573 Org: User:
Start: 09/30/24 End: 10/31/29 Due: 10/31/30

Intergroup Randomized Trial for Children or Adolescents With B-Cell Non Hodgkin Lymphoma or B-Acute Leukemia: Rituximab Evaluation in High Risk Patients

Phase: N/A Priority: Normal
NCT ID: NCT01516580 Org: User:
Start: 12/31/11 End: 12/31/21 Due: 12/31/22

Phase III Trial Comparing Methotrexate and Cetuximab in First-line Treatment of Recurrent and/or Metastatic Squamous Cell Head and Neck Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01884623 Org: User:
Start: 11/06/13 End: 10/12/21 Due: 10/12/22

Dose Escalation of Cisplatin Hyperthermic Intraperitoneal Chemotherapy After Surgery in Patients With Unresectable Stage IIIC Ovarian, Tube or Peritoneal Primary Adenocarcinoma

Phase: N/A Priority: Normal
NCT ID: NCT02217956 Org: User:
Start: 06/30/11 End: 06/30/15 Due: 06/30/16

Study Assessing the Efficacy and Safety of cANnabidiol Oral Solution for Joint Pain of Adjuvant enDOcrine theRApy in Patients With Early Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT06787118 Org: User:
Start: 02/28/25 End: 05/31/27 Due: 05/31/28

Study Evaluating Neoadjuvant Pembrolizumab Monotherapy in Patients With Muscle-Invasive Bladder Cancer to Explore in Vivo the Mechanisms of Action of Pembrolizumab

Phase: N/A Priority: Normal
NCT ID: NCT03212651 Org: User:
Start: 10/17/17 End: 12/13/19 Due: 12/13/20

Trial of a Vaccination With Tumor Antigen-loaded Dendritic Cell-derived Exosomes

Phase: N/A Priority: Normal
NCT ID: NCT01159288 Org: User:
Start: 05/19/10 End: 12/19/15 Due: 12/19/16

Combination Chemotherapy Plus Radiation Therapy in Treating Patients With Small Cell Lung Cancer

Phase: N/A Priority: Normal
NCT ID: NCT00002858 Org: User:
Start: 03/31/93 End: - Due: -

Peripheral Primitive Fibromatosis

Phase: N/A Priority: Normal
NCT ID: NCT01801176 Org: User:
Start: 05/31/12 End: 05/31/18 Due: 05/31/19

Studies of Temozolomide in Combination With Topotecan in Refractory and Relapsed Paediatric Solid Tumours

Phase: N/A Priority: Normal
NCT ID: NCT00918320 Org: User:
Start: 06/30/09 End: 08/31/15 Due: 08/31/16

Measurement of Cardiac Index Using an Implanted Central Venous Access Port in Patients Scheduled for Oncologic High-risk Surgery

Phase: N/A Priority: Normal
NCT ID: NCT02063009 Org: User:
Start: 10/31/12 End: 01/31/13 Due: 01/31/14

Video-Based Cognitive Behavioral Therapy for Insomnia in Adults Cancer Patients and Survivors

Phase: N/A Priority: Normal
NCT ID: NCT03981666 Org: User:
Start: 05/04/18 End: 02/10/19 Due: 02/10/20

Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults

Phase: N/A Priority: Normal
NCT ID: NCT04477681 Org: User:
Start: 04/09/20 End: 04/30/27 Due: 04/30/28

Trial Comparing Two Protocols of re Irradiation in an Irradiated Area for Carcinoma of the Upper Aerodigestive Tract

Phase: N/A Priority: Normal
NCT ID: NCT01211938 Org: User:
Start: 06/15/10 End: 02/25/17 Due: 02/25/18

Nivolumab for Pediatric and Adult Relapsing/Refractory ALK+, for Evaluation of Response in Patients With Progressive Disease (Cohort 1) or as Consolidative Immunotherapy in Patients in Complete Remission After Relapse (Cohort 2)

Phase: N/A Priority: Normal
NCT ID: NCT03703050 Org: User:
Start: 01/02/19 End: 09/30/25 Due: 09/30/26